glp-1 obesity drug news today september 2025 How Supply and Demand for Weight Loss Drugs is Playing Out in 2026 How GLP-1s Are Shaping Beauty
Description
E.MatthayM
The 3 most-prescribed GLP-1 receptor agonists are - glu tide smnemonic glu e tide
Haadia Waheed, orcid.org/0009-0005-4387-1580
This made it possible to discover peptides in low abundance, including hormone precursors and processing intermediates which could not be characterised by other means at the time
weight loss at target dose (trial data) ~21% (SURMOUNT) CV risk reduction labelled Under study Format Prefilled KwikPen + single-dose autoinjector India price (May 2026) 14,00027,500/month DCGI-approved Yes (March 2025) Generic competition in India No no Indian biosimilar yet Weight-loss percentages are trial averages at target dose individual response varies
Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Provides Neuroprotection in Mice Transient Focal Cerebral Ischemia
